Skip to main content
SpringerLink
Log in

PTEN and Cancer

  • Protocol
Tumor Suppressor Genes

Part of the book series: Methods in Molecular Biology™ ((MIMB,volume 222))

Abstract

Genetic evidence strongly suggested that a tumor suppressor was located on chromosome 10. During the development of glioblastoma, one copy of chromosome 10 was typically lost (1). Cytogenetic and molecular analysis revealed partial or complete loss of chromosome 10 in bladder, endometrial, and prostate cancer (2,3). These studies implicated 10q23 as a chromosomal region likely to contain one or more important tumor suppressor genes. When wild-type chromosome 10 was reintroduced into glioblastoma cell lines, it reduced the ability of these cell lines to form tumors in nude mice, in part due to inhibition of angiogensis (4). During the same year (1996), a linkage analysis report of a cancer predisposition syndrome, Cowden disease (CD), determined that a CD locus was present on chromosome10q23 (5). These findings greatly bolstered the idea that chromosome 10q23 contained a novel tumor suppressor gene whose loss was key in the formation of several types of cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Protocol
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Bigner, S. H., Mark, J., Mahaley, M. S., and Bigner, D. D. (1984) Patterns of the early, gross chromosomal changes in malignant human gliomas. Hereditas 101, 103–113.

    Article  PubMed  CAS  Google Scholar 

  2. Lundgren, R., Kristoffersson, U., Heim, S., Mandahl, N., and Mitelman, F. (1988) Multiple structural chromosome rearrangements, including del(7q) and del(10q), in an adenocarcinoma of the prostate. Cancer Genet. Cytogenet. 35, 103–108.

    Article  PubMed  CAS  Google Scholar 

  3. Gibas, Z., Prout, G. R., Jr., Connolly, J. G., Pontes, J. E., and Sandberg, A. A. (1984) Nonrandom chromosomal changes in transitional cell carcinoma of the bladder. Cancer Res. 44, 1257–1264.

    PubMed  CAS  Google Scholar 

  4. Hsu, S. C., Volpert, O. V., Steck, P. A., et al. (1996) Inhibition of angiogenesis in human glioblastomas by chromosome 10 induction of thrombospondin-1. Cancer Res. 56, 5684–5691.

    PubMed  CAS  Google Scholar 

  5. Nelen, M. R., Padberg, G. W., Peeters, E. A., et al. (1996) Localization of the gene for Cowden disease to chromosome 10q22–23. Nat. Genet. 13, 114–116.

    Article  PubMed  CAS  Google Scholar 

  6. Li, J., Yen, C., Liaw, D., et al. (1997) R. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer [see comments]. Science 275, 1943–1947.

    Article  PubMed  CAS  Google Scholar 

  7. Steck, P. A., Pershouse, M. A., Jasser, S. A., et al. (1997) Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nat. Genet. 15, 356–362.

    Article  PubMed  CAS  Google Scholar 

  8. Li, D. M. and Sun, H. (9197) TEP1, encoded by a candidate tumor suppressor locus, is a novel protein tyrosine phosphatase regulated by transforming growth factor beta. Cancer Res. 57, 2124–2129.

    Google Scholar 

  9. Wang, S. I., Puc, J., Li, J., et al. (1997) Somatic mutations of PTEN in glioblastoma multiforme. Cancer Res. 57, 4183–4186.

    PubMed  CAS  Google Scholar 

  10. Liu, W., James, C. D., Frederick, L., Alderete, B. E., and Jenkins, R. B. (1997) PTEN/MMAC1 mutations and EGFR amplification in glioblastomas. Cancer Res. 57, 5254–5257.

    PubMed  CAS  Google Scholar 

  11. Duerr, E. M., Rollbrocker, B., Hayashi, Y., et al. (1998) PTEN mutations in gliomas and glioneuronal tumors. Oncogene 16, 2259–2264.

    Article  PubMed  CAS  Google Scholar 

  12. Teng, D. H., Hu, R., Lin, H., et al. (1997) MMAC1/PTEN mutations in primary tumor specimens and tumor cell lines. Cancer Res. 57, 5221–5225.

    PubMed  CAS  Google Scholar 

  13. Chiariello, E., Roz, L., Albarosa, R., Magnani, I., and Finocchiaro, G. (1998) PTEN/MMAC1 mutations in primary glioblastomas and short-term cultures of malignant gliomas. Oncogene 16, 541–545.

    Article  PubMed  CAS  Google Scholar 

  14. Sano, T., Lin, H., Chen, X., et al. (1999) Differential expression of MMAC/PTEN in glioblastoma multiforme: relationship to localization and prognosis. Cancer Res. 59, 1820–1824.

    PubMed  CAS  Google Scholar 

  15. Ittmann, M. (1996) Allelic loss on chromosome 10 in prostate adenocarcinoma. Cancer Res. 56, 2143–2147.

    PubMed  CAS  Google Scholar 

  16. Gray, I. C., Phillips, S. M., Lee, S. J., Neoptolemos, J. P., Weissenbach, J., and Spurr, N. K. (1995) Loss of the chromosomal region 10q23–25 in prostate cancer. Cancer Res. 55, 4800–4803.

    PubMed  CAS  Google Scholar 

  17. Komiya, A., Suzuki, H., Ueda, T., et al. (1996) Allelic losses at loci on chromosome 10 are associated with metastasis and progression of human prostate cancer. Genes Chromosomes Cancer 17, 245–253.

    Article  PubMed  CAS  Google Scholar 

  18. Trybus, T. M., Burgess, A. C., Wojno, K. J., Glover, T. W., and Macoska, J. A. (1996) Distinct areas of allelic loss on chromosomal regions 10p and 10q in human prostate cancer. Cancer Res. 56, 2263–2267.

    PubMed  CAS  Google Scholar 

  19. Cairns, P., Okami, K., Halachmi, S., et al. (1997) Frequent inactivation of PTEN/MMAC1 in primary prostate cancer. Cancer Res. 57, 4997–5000.

    PubMed  CAS  Google Scholar 

  20. Whang, Y. E., Wu, X., Suzuki, H., et al. (1998) Inactivation of the tumor suppressor PTEN/MMAC1 in advanced human prostate cancer through loss of expression. Proc. Natl. Acad. Sci. USA 95, 5246–5250.

    Article  PubMed  CAS  Google Scholar 

  21. McMenamin, M. E., Soung, P., Perera, S., Kaplan, I., Loda, M., and Sellers, W. R. (1999) Loss of PTEN expression in paraffin-embedded primary prostate cancer correlates with high Gleason score and advanced stage. Cancer Res. 59, 4291–4296.

    PubMed  CAS  Google Scholar 

  22. Parmiter, A. H., Balaban, G., Clark, W. H., Jr., and Nowell, P. C. (1988) Possible involvement of the chromosome region 10q24–q26 in early stages of melanocytic neoplasia. Cancer Genet. Cytogenet. 30, 313–317.

    Article  PubMed  CAS  Google Scholar 

  23. Richmond, A., Fine, R., Murray, D., Lawson, D. H., and Priest, J. H. (1986) Growth factor and cytogenetic abnormalities in cultured nevi and malignant melanomas. J. Invest. Dermatol. 86, 295–302.

    Article  PubMed  CAS  Google Scholar 

  24. Healy, E., Belgaid, C. E., Takata, M., et al. (1996) Allelotypes of primary cutaneous melanoma and benign melanocytic nevi. Cancer Res. 56, 589–593.

    PubMed  CAS  Google Scholar 

  25. Healy, E., Rehman, I., Angus, B., and Rees, J. L. (1995) Loss of heterozygosity in sporadic primary cutaneous melanoma. Genes Chromosomes Cancer 12, 152–156.

    Article  PubMed  CAS  Google Scholar 

  26. Herbst, R. A., Weiss, J., Ehnis, A., Cavenee, W. K., and Arden, K. (1994) C. Loss of heterozygosity for 10q22-10qter in malignant melanoma progression. Cancer Res. 54, 3111–3114.

    PubMed  CAS  Google Scholar 

  27. Guldberg, P., thor Straten, P., Birck, A., Ahrenkiel, V., Kirkin, A. F., and Zeuthen, J. (1997) Disruption of the MMAC1/PTEN gene by deletion or mutation is a frequent event in malignant melanoma. Cancer Res. 57, 3660–3663.

    PubMed  CAS  Google Scholar 

  28. Tsao, H., Zhang, X., Benoit, E., and Haluska, F. G. (1998) Identification of PTEN/MMAC1 alterations in uncultured melanomas and melanoma cell lines. Oncogene 16, 3397–3402.

    Article  PubMed  CAS  Google Scholar 

  29. Reifenberger, J., Wolter, M., Bostrom, J., et al. (2000) Allelic losses on chromosome arm 10q and mutation of the PTEN (MMAC1) tumour suppressor gene in primary and metastatic malignant melanomas. Virchows Arch. 436, 487–493.

    Article  PubMed  CAS  Google Scholar 

  30. Zhou, X. P., Gimm, O., Hampel, H., Niemann, T., Walker, M. J., and Eng, C. (2000) Epigenetic PTEN silencing in malignant melanomas without PTEN mutation [In Process Citation]. Am. J. Pathol. 157, 1123–1128.

    Article  PubMed  CAS  Google Scholar 

  31. Tsao, H., Zhang, X., Fowlkes, K., and Haluska, F. G. (2000) Relative reciprocity of NRAS and PTEN/MMAC1 alterations in cutaneous melanoma cell lines. Cancer Res. 60, 1800–1804.

    PubMed  CAS  Google Scholar 

  32. Ueda, K., Nishijima, M., Inui, H., et al. (1998) Infrequent mutations in the PTEN/MMAC1 gene among primary breast cancers. Jpn. J. Cancer Res. 89, 17–21.

    Article  PubMed  CAS  Google Scholar 

  33. Rhei, E., Kang, L., Bogomolniy, F., Federici, M. G., Borgen, P. I., and Boyd, J. (1997) Mutation analysis of the putative tumor suppressor gene PTEN/MMAC1 in primary breast carcinomas. Cancer Res. 57, 3657–3659.

    PubMed  CAS  Google Scholar 

  34. Bose, S., Wang, S. I., Terry, M. B., Hibshoosh, H., and Parsons, R. (1998) Allelic loss of chromosome 10q23 is associated with tumor progression in breast carcinomas. Oncogene 17, 123–127.

    Article  PubMed  CAS  Google Scholar 

  35. Feilotter, H. E., Coulon, V., McVeigh, J. L., et al. (1999) Analysis of the 10q23 chromosomal region and the PTEN gene in human sporadic breast carcinoma. Br. J. Cancer 79, 718–723.

    Article  PubMed  CAS  Google Scholar 

  36. Perren, A., Weng, L. P., Boag, A. H., et al. (1999) Immunohistochemical evidence of loss of PTEN expression in primary ductal adenocarcinomas of the breast. Am. J. Pathol. 155, 1253–1260.

    Article  PubMed  CAS  Google Scholar 

  37. Yokomizo, A., Tindall, D. J., Drabkin, H., et al. (1998) PTEN/MMAC1 mutations identified in small cell, but not in non-small cell lung cancers. Oncogene 17, 475–479

    Article  PubMed  CAS  Google Scholar 

  38. Kohno, T., Takahashi, M., Manda, R., and Yokota, J. (1998) Inactivation of the PTEN/MMAC1/TEP1 gene in human lung cancers. Genes Chromosomes Cancer 22, 152–156.

    Article  PubMed  CAS  Google Scholar 

  39. Cairns, P., Evron, E., Okami, K., et al. (1998) Point mutation and homozygous deletion of PTEN/MMAC1 in primary bladder cancers. Oncogene 16, 3215–3218.

    Article  PubMed  CAS  Google Scholar 

  40. Gronbaek, K., Zeuthen, J., Guldberg, P., Ralfkiaer, E., and Hou-Jensen, K. (1998) Alterations of the MMAC1/PTEN gene in lymphoid malignancies [letter]. Blood 91, 4388–4390.

    PubMed  CAS  Google Scholar 

  41. Kim, S. K., Su, L. K., Oh, Y., Kemp, B. L., Hong, W. K., and Mao, L. (1998) Alterations of PTEN/MMAC1, a candidate tumor suppressor gene, and its homologue, PTH2, in small cell lung cancer cell lines. Oncogene 16, 89–93.

    Article  PubMed  CAS  Google Scholar 

  42. Peiffer, S. L., Herzog, T. J., Tribune, D. J., Mutch, D. G., Gersell, D. J., and Goodfellow, P. J. (1995) Allelic loss of sequences from the long arm of chromosome 10 and replication errors in endometrial cancers. Cancer Res. 55, 1922–1926.

    PubMed  CAS  Google Scholar 

  43. Nagase, S., Sato, S., Tezuka, F., Wada, Y., Yajima, A., and Horii, A. (1996) Deletion mapping on chromosome 10q25–q26 in human endometrial cancer. Br. J. Cancer 74, 1979–1983.

    Article  PubMed  CAS  Google Scholar 

  44. Risinger, J. I., Hayes, A. K., Berchuck, A., and Barrett, J. C. (1997) PTEN/MMAC1 mutations in endometrial cancers. Cancer Res. 57, 4736–4738.

    PubMed  CAS  Google Scholar 

  45. Tashiro, H., Blazes, M. S., Wu, R., et al. (1997) Mutations in PTEN are frequent in endometrial carcinoma but rare in other common gynecological malignancies. Cancer Res. 57, 3935–3940.

    PubMed  CAS  Google Scholar 

  46. Mutter, G. L., Lin, M. C., Fitzgerald, J. T., et al. (2000) Altered PTEN expression as a diagnostic marker for the earliest endometrial precancers [see comments]. J. Natl. Cancer Inst. 92, 924–930.

    Article  PubMed  CAS  Google Scholar 

  47. Obata, K., Morland, S. J., Watson, R. H., et al. (1998) Frequent PTEN/MMAC mutations in endometrioid but not serous or mucinous epithelial ovarian tumors. Cancer Res. 58, 2095–2097.

    PubMed  CAS  Google Scholar 

  48. Su, T. H., Chang, J. G., Perng, L. I., et al. (2000) Mutation analysis of the putative tumor suppressor gene PTEN/MMAC1 in cervical cancer. Gynecol. Oncol. 76, 193–199.

    Article  PubMed  CAS  Google Scholar 

  49. Liaw, D., Marsh, D. J., Li, J., et al. (1997) Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome. Nat. Genet. 16, 64–67.

    Article  PubMed  CAS  Google Scholar 

  50. Marsh, D. J., Coulon, V., Lunetta, K. L., et al. (1998) Mutation spectrum and genotype-phenotype analyses in Cowden disease and Bannayan-Zonana syndrome, two hamartoma syndromes with germline PTEN mutation. Hum. Mol. Genet. 7, 507–515.

    Article  PubMed  CAS  Google Scholar 

  51. Marsh, D. J., Dahia, P. L., Coulon, V., et al. (1998) Allelic imbalance, including deletion of PTEN/MMACI, at the Cowden disease locus on 10q22–23, in hamartomas from patients with Cowden syndrome and germline PTEN mutation. Genes Chromosomes Cancer 21, 61–69.

    Article  PubMed  CAS  Google Scholar 

  52. Marsh, D. J., Dahia, P. L., Zheng, Z., et al. (1997) Germline mutations in PTEN are present in Bannayan-Zonana syndrome [letter]. Nat. Genet. 16, 333–334.

    Article  PubMed  CAS  Google Scholar 

  53. Li, D. M. and Sun, H. (1998) PTEN/MMAC1/TEP1 suppresses the tumorigenicity and induces G1 cell cycle arrest in human glioblastoma cells. Proc. Nat. Acad. Sci. USA 95, 15406–15411.

    Article  PubMed  CAS  Google Scholar 

  54. Furnari, F. B., Huang, H. J., and Cavenee, W. K. (1998) The phosphoinositol phosphatase activity of PTEN mediates a serum-sensitive G1 growth arrest in glioma cells. Cancer Res. 58, 5002–5008.

    PubMed  CAS  Google Scholar 

  55. Davies, M. A., Lu, Y., Sano, T., et al. (1998) Adenoviral transgene expression of MMAC/PTEN in human glioma cells inhibits Akt activation and induces anoikis. Cancer Res. 58, 5285–5290.

    PubMed  CAS  Google Scholar 

  56. Li, J., Simpson, L., Takahashi, M., et al. (1998) The PTEN/MMAC1 tumor suppressor induces cell death that is rescued by the AKT/protein kinase B oncogene. Cancer Res. 58, 5667–5672.

    PubMed  CAS  Google Scholar 

  57. Weng, L. P., Smith, W. M., Dahia, P. L., et al. (1999) PTEN suppresses breast cancer cell growth by phosphatase activity-dependent G1 arrest followed by cell death. Cancer Res. 59, 5808–5814.

    PubMed  CAS  Google Scholar 

  58. Zhu, X., Kwon, C. H., Schlosshauer, P. W., Ellenson, L. H., and Baker, S. J. (2001) PTEN induces G(1) cell cycle arrest and decreases cyclin D3 levels in endometrial carcinoma cells. Cancer Res. 61, 4569–4575.

    PubMed  CAS  Google Scholar 

  59. Wen, S., Stolarov, J., Myers, M. P., et al. (2001) PTEN controls tumor-induced angiogenesis. Proc. Natl. Acad. Sci. USA. 98, 4622–4627.

    Article  PubMed  CAS  Google Scholar 

  60. Zundel, W., Schindler, C, Haas-Kogan, D., et al. (2000) Loss of PTEN facilitates HIF-1-mediated gene expression. Genes Dev. 14, 391–396.

    PubMed  CAS  Google Scholar 

  61. Podsypanina, K., Ellenson, L. H., Nemes, A., et al. (1999) Mutation of Pten/Mmac1 in mice causes neoplasia in multiple organ systems. Proc. Natl. Acad. Sci. USA 96, 1563–1568.

    Article  PubMed  CAS  Google Scholar 

  62. Di Cristofano, A., Pesce, B., Cordon-Cardo, C., and Pandolfi, P. P. (1998) Pten is essential for embryonic development and tumour suppression. Nat. Genet. 19, 348–355.

    Article  PubMed  Google Scholar 

  63. Stambolic, V, Suzuki, A., de la Pompa, J. L., et al. (1998) Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN. Cell 95, 29–39.

    Article  PubMed  CAS  Google Scholar 

  64. Di Cristofano, A., Kotsi, P., Peng, Y. F, Cordon-Cardo, C, Elkon, K. B., and Pandolfi, P. P. (1999) Impaired Fas response and autoimmunity in Pten+/− mice. Science 285, 2122–2125.

    Article  PubMed  Google Scholar 

  65. Li, Y, Podsypanina, K., Liu, X., et al. (2001) Deficiency of Pten accelerates mammary oncogenesis in MMTV-Wnt-1 transgenic mice. BMC Mol. Biol. 2, 2.

    Article  PubMed  CAS  Google Scholar 

  66. Di Cristofano, A., De Acetis, M., Koff, A., Cordon-Cardo, C, and Pandolfi, P. P. (2001) Pten and p27KIP1 cooperate in prostate cancer tumor suppression in the mouse. Nat. Genet. 27, 222–224.

    Article  PubMed  CAS  Google Scholar 

  67. Scanga, S. E., Ruel, L., Binari, R. C, et al. (2000) The conserved PI3′K/PTEN/Akt signaling pathway regulates both cell size and survival in Drosophila. Oncogene 19, 3971–3977.

    Article  PubMed  CAS  Google Scholar 

  68. Huang, H., Potter, C. J., Tao, W., et al. (1999) PTEN affects cell size, cell proliferation and apoptosis during Drosophila eye development. Development 126, 5365–5372.

    PubMed  CAS  Google Scholar 

  69. Gao, X., Neufeld T. P., and Pan, D., Drosophila (2000) PTEN regulates cell growth and proliferation through PI3K-dependent and-independent pathways. Dev. Biol. 221, 404–418.

    Article  PubMed  CAS  Google Scholar 

  70. Goberdhan, D. C, Paricio, N, Goodman, E. C, Mlodzik, M., and Wilson, C. (1999) Drosophila tumor suppressor PTEN controls cell size and number by antagonizing the Chico/PI3-kinase signaling pathway. Genes Dev. 13, 3244–3258.

    Article  PubMed  CAS  Google Scholar 

  71. Myers, M. P., Stolarov, J. P., Eng, C, et al. (1997) P-TEN, the tumor suppressor from human chromosome 10q23, is a dual-specificity phosphatase. Proc. Natl. Acad. Sci. USA. 94, 9052–9057.

    Article  PubMed  CAS  Google Scholar 

  72. Maehama, T. and Dixon, J. E. (1998) The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate. J. Biol. Chem. 273, 13375–13378.

    Article  PubMed  CAS  Google Scholar 

  73. Myers, M. P., Pass, I., Batty, I. H., et al. (1998) The lipid phosphatase activity of PTEN is critical for its tumor supressor function. Proc. Natl. Acad. Sci. USA 95, 13513–13518.

    Article  PubMed  CAS  Google Scholar 

  74. Furnari, F. B., Huang, H. J., and Cavenee, W. K. (1998) The phosphoinositol phosphatase activity of PTEN mediates a serum-sensitive G1 growth arrest in glioma cells. Cancer Res. 58, 5002–5008.

    PubMed  CAS  Google Scholar 

  75. Datta, S. R., Brunet, A., and Greenberg, M. E. (1999) Cellular survival: a play in three Akts. Genes Dev. 13, 2905–2927.

    Article  PubMed  CAS  Google Scholar 

  76. Kimura, K. D., Tissenbaum, H. A., Liu, Y., and Ruvkun, G. (1997) daf-2, an insulin receptor-like gene that regulates longevity and diapause in Caenorhabditis elegans [see comments]. Science 277, 942–946.

    Article  PubMed  CAS  Google Scholar 

  77. Vowels, J. J. and Thomas, J. H. (1992) Genetic analysis of chemosensory control of dauer formation in Caenorhabditis elegans. Genetics 130, 105–123.

    PubMed  CAS  Google Scholar 

  78. Gottlieb, S. and Ruvkun, G. (1994) daf-2, daf-16 and daf-23: genetically interacting genes controlling Dauer formation in Caenorhabditis elegans. Genetics 137, 107–120.

    PubMed  CAS  Google Scholar 

  79. Larsen, P. L., Albert, P. S., and Riddle, D. L. (1995) Genes that regulate both development and longevity in Caenorhabditis elegans. Genetics 139, 1567–1583.

    PubMed  CAS  Google Scholar 

  80. Morris, J. Z., Tissenbaum, H. A., and Ruvkun, G. (1996) A phosphatidylinositol-3-OH kinase family member regulating longevity and diapause in Caenorhabditis elegans. Nature 382, 536–539.

    Article  PubMed  CAS  Google Scholar 

  81. Paradis, S. and Ruvkun, G. (1998) Caenorhabditis elegans Akt/PKB transduces insulin receptor-like signals from AGE-1 PI3 kinase to the DAF-16 transcription factor. Genes Dev. 12, 2488–2498.

    Article  PubMed  CAS  Google Scholar 

  82. Ogg, S. and Ruvkun, G. (1998) The C. elegans PTEN homolog, DAF-18, acts in the insulin receptor-like metabolic signaling pathway [In Process Citation]. Mol. Cell 2, 887–893.

    Article  PubMed  CAS  Google Scholar 

  83. Gil, E. B., Malone Link, E., Liu, L. X., Johnson, C. D, and Lees, J. A. (1999) Regulation of the insulin-like developmental pathway of Caenorhabditis elegans by a homolog of the PTEN tumor suppressor gene. Proc. Natl. Acad. Sci. USA 96, 2925–2930.

    Google Scholar 

  84. Rouault, J. P., Kuwabara, P. E., Sinilnikova, O. M., Duret, L., Thierry-Mieg, D, and Billaud, M. (1999) Regulation of dauer larva development in Caenorhabditis elegans by daf-18, a homologue of the tumour suppressor PTEN. Curr. Biol. 9, 329–332.

    Article  PubMed  CAS  Google Scholar 

  85. Leevers, S. J., Weinkove, D., MacDougall, L. K., Hafen, E., and Waterfield M. D. (1996) The Drosophila phosphoinositide 3-kinase Dp110 promotes cell growth. EMBO J. 15, 6584–6594.

    PubMed  CAS  Google Scholar 

  86. Wu, X., Senechal, K., Neshat, M. S., Whang, Y. E., and Sawyers, C. L. (1998) The PTEN/MMAC1 tumor suppressor phosphatase functions as a negative regulator of the phosphoinositide 3-kinase/Akt pathway. Proc. Natl. Acad. Sci. USA 95, 15587–15591.

    Article  PubMed  CAS  Google Scholar 

  87. Ramaswamy, S., Nakamura, N, Vazquez, F, et al. (1999) Regulation of G1 progression by the PTEN tumor suppressor protein is linked to inhibition of the phosphatidylinositol 3-kinase/Akt pathway [In Process Citation]. Proc. Natl. Acad. Sci. USA 96, 2110–2115.

    Article  PubMed  CAS  Google Scholar 

  88. Dahia, P. L., Aguiar, R. C, Alberta, J., et al. (1999) PTEN is inversely correlated with the cell survival factor Akt/PKB and is inactivated via multiple mechanismsin haematological malignancies. Hum. Mol. Genet. 8, 185–193.

    Article  PubMed  CAS  Google Scholar 

  89. Stambolic, V, Tsao, M. S., Macpherson, D, Suzuki, A., Chapman, W. B., and Mak, T. W. (2000) High incidence of breast and endometrial neoplasia resembling human Cowden syndrome in pten+/− mice. Cancer Res. 60, 3605–3611.

    PubMed  CAS  Google Scholar 

  90. Dufner, A. and Thomas, G. (1999) Ribosomal S6 kinase signaling and the control of translation. Exp. Cell Res. 253, 100–109.

    Article  PubMed  CAS  Google Scholar 

  91. Zhang, H., Stallock, J. P., Ng, J. C, Reinhard C., and Neufeld T. P. (2000) Regulation of cellular growth by the Drosophila target of rapamycin dTOR. Genes Dev. 14, 2712–2724.

    Article  PubMed  CAS  Google Scholar 

  92. Oldham, S., Montagne, J., Radimerski, T, Thomas, G., and Hafen, E. (2000) Genetic and biochemical characterization of dTOR, the Drosophila homolog of the target of rapamycin. Genes Dev. 14, 2689–2694.

    Article  PubMed  CAS  Google Scholar 

  93. Nakashima, N., Sharma, P. M., Imamura, T., Bookstein, R., and Olefsky, J. M. (2000) The tumor suppressor PTEN negatively regulates insulin signaling in 3T3-L1 adipocytes. J. Biol. Chem. 275, 12889–12895.

    Article  PubMed  CAS  Google Scholar 

  94. Lu, Y., Lin, Y. Z., LaPushin, R., et al. (1999) The PTEN/MMAC1/TEP tumor suppressor gene decreases cell growth and induces apoptosis and anoikis in breast cancer cells. Oncogene 18, 7034–7045.

    Article  PubMed  CAS  Google Scholar 

  95. Simpson, L., Li, J., Liaw, D., et al. (2001) PTEN expression causes feedback upregulation of insulin receptor substrate 2. Mol. Cell Biol. 21, 3947–3958.

    Article  PubMed  CAS  Google Scholar 

  96. Weng, L. P., Smith, W. M., Brown, J. L., and Eng, C. (2001) PTEN inhibits insulin-stimulated MEK/MAPK activation and cell growth by blocking IRS-1 phosphorylation and IRS-1/Grb-2/Sos complex formation in a breast cancer model. Hum. Mol. Genet. 10, 605–616.

    Article  PubMed  CAS  Google Scholar 

  97. Gingras, A. C., Kennedy, S. G., O′ Leary, M. A., Sonenberg, N., and Hay, N. (1998) 4E-BP1, a repressor of mRNA translation, is phosphorylated and inactivated by the Akt(PKB) signaling pathway. Genes Dev. 12, 502–513.

    Article  PubMed  CAS  Google Scholar 

  98. Kohn, A. D., Barthel, A., Kovacina, K. S., et al. (1998) Construction and characterization of a conditionally active version of the serine/threonine kinase Akt. J. Biol. Chem. 273, 11937–11943.

    Article  PubMed  CAS  Google Scholar 

  99. Sun, H., Lesche, R., Li, D. M., et al. (1999) PTEN modulates cell cycle progression and cell survival by regulating phosphatidylinositol 3,4,5,-trisphosphate and Akt/protein kinase B signaling pathway. Proc. Natl. Acad. Sci. USA 96, 6199–6204.

    Article  PubMed  CAS  Google Scholar 

  100. Kenyon, C., Chang, J., Gensch, E., Rudner, A., and Tabtiang, R. (1993) A C. elegans mutant that lives twice as long as wild type [see comments]. Nature 366, 461–464.

    Article  PubMed  CAS  Google Scholar 

  101. Dorman, J. B., Albinder, B., Shroyer, T., and Kenyon, C. (1995) The age-1 and daf-2 genes function in a common pathway to control the lifespan of Caenorhabditis elegans. Genetics 141, 1399–1406.

    PubMed  CAS  Google Scholar 

  102. Lin, K., Dorman, J. B., Rodan, A., and Kenyon, C. (1997) daf-16: An HNF-3/forkhead family member that can function to double the life-span of Caenorhabditis elegans [see comments]. Science 278, 1319–1322.

    Article  PubMed  CAS  Google Scholar 

  103. Ogg, S., Paradis, S., Gottlieb, S., et al. (1997) The Fork head transcription factor DAF-16 transduces insulin-like metabolic and longevity signals in C. elegans. Nature 389, 994–999.

    Article  PubMed  CAS  Google Scholar 

  104. Brunet, A., Bonni, A., Zigmond, M. J., et al. (1999) Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 96, 857–868.

    Article  PubMed  CAS  Google Scholar 

  105. Kops, G. J., de Ruiter, N. D., De Vries-Smits, A. M., Powell, D. R., Bos, J. L., and Burger-ing, B. M. (1999) Direct control of the Forkhead transcription factor AFX by protein kinase B. Nature 398, 630–634.

    Article  PubMed  CAS  Google Scholar 

  106. Tang, E. D., Nunez, G., Barr, F. G., and Guan, K. L. (1999) Negative regulation of the forkhead transcription factor FKHR by Akt. J. Biol. Chem. 274, 16741–16746.

    Article  PubMed  CAS  Google Scholar 

  107. Guo, S., Rena, G., Cichy, S., He, X., Cohen, P., and Unterman, T. (1999) Phosphorylation of serine 256 by protein kinase B disrupts transactivation by FKHR and mediates effects of insulin on insulin-like growth factor-binding protein-1 promoter activity through a conserved insulin response sequence. J. Biol. Chem. 274, 17184–17192.

    Article  PubMed  CAS  Google Scholar 

  108. Nakae, J., Park, B. C., and Accili, D. (1999) Insulin stimulates phosphorylation of the forkhead transcription factor FKHR on serine 253 through a Wortmannin-sensitive pathway. J. Biol. Chem. 274, 15982–15985.

    Article  PubMed  CAS  Google Scholar 

  109. Medema, R. H., Kops, G. J., Bos, J. L., and Burgering, B. M. (2000) AFX-like Forkhead transcription factors mediate cell-cycle regulation by Ras and PKB through p27kip1. Nature 404, 782–787.

    Article  PubMed  CAS  Google Scholar 

  110. Nakamura, N., Ramaswamy, S., Vazquez, F., Signoretti, S., Loda, M., and Sellers, W. R. (2000) Forkhead transcription factors are critical effectors of cell death and cell cycle arrest downstream of PTEN. Mol. Cell. Biol. 20, 8969–8982.

    Article  PubMed  CAS  Google Scholar 

  111. Warren, R. S., Yuan, H., Matli, M. R., Ferrara, N., and Donner, D. B. (1996) Induction of vascular endothelial growth factor by insulin-like growth factor 1 in colorectal carcinoma. J. Biol. Chem. 271, 29483–29488.

    Article  PubMed  CAS  Google Scholar 

  112. Mazure, N. M., Chen, E. Y., Laderoute, K. R., and Giaccia, A. J. (1997) Induction of vascular endothelial growth factor by hypoxia is modulated by a phosphatidylinositol 3-kinase/Akt signaling pathway in Ha-ras-transformed cells through a hypoxia inducible factor-1 transcriptional element. Blood 90, 3322–3331.

    PubMed  CAS  Google Scholar 

  113. Zelzer, E., Levy, Y., Kahana, C., Shilo, B. Z., Rubinstein, M., and Cohen, B. (1998) Insulin induces transcription of target genes through the hypoxia-inducible factor HIF-1alpha/ARNT. EMBO J. 17, 5085–5094.

    Article  PubMed  CAS  Google Scholar 

  114. Zhong, H., Chiles, K., Feldser, D., et al. (2000) Modulation of hypoxia-inducible factor 1alpha expression by the epidermal growth factor/phosphatidylinositol 3-kinase/PTEN/AKT/FRAP pathway in human prostate cancer cells: implications for tumor angiogenesis and therapeutics. Cancer Res. 60, 1541–1545.

    PubMed  CAS  Google Scholar 

  115. Wang, X., Gjorloff-Wingren, A., Saxena, M., Pathan, N., Reed, J. C., and Mustelin, T., (2000) The tumor suppressor PTEN regulates T cell survival and antigen receptor signaling by acting as a phosphatidylinositol 3-phosphatase. J. Immunol. 164, 1934–1939.

    PubMed  CAS  Google Scholar 

  116. Shan, X., Czar, M. J., Bunnell, S. C., et al. (2000) Deficiency of PTEN in Jurkat T cells causes constitutive localization of Itk to the plasma membrane and hyperresponsiveness to CD3 stimulation. Mol. Cell. Biol. 20, 6945–6957.

    Article  PubMed  CAS  Google Scholar 

  117. Lee, J. O., Yang, H., Georgescu, M. M., et al. (1999) Crystal structure of the PTEN tumor suppressor: implications for its phosphoinositide phosphatase activity and membrane association. Cell 99, 323–334.

    Article  PubMed  CAS  Google Scholar 

  118. Georgescu, M. M., Kirsch, K. H., Akagi, T., Shishido, T., and Hanafusa, H. (1999) The tumor-suppressor activity of PTEN is regulated by its carboxyl-terminal region. Proc. Natl. Acad. Sci. USA 96, 10182–10187.

    Article  PubMed  CAS  Google Scholar 

  119. Vazquez, F., Ramaswamy, S., Nakamura, N., and Sellers, W. R. (2000) Phosphorylation of the PTEN tail regulates protein stability and function [In Process Citation]. Mol. Cell. Biol. 20, 5010–5018.

    Article  PubMed  CAS  Google Scholar 

  120. Torres, J. and Pulido, R. (2001) The tumor suppressor PTEN is phosphorylated by the protein kinase CK2 at its C-terminus: implications for PTEN stability to proteasome-mediated degradation. J. Biol. Chem. 12, 993–998.

    Article  Google Scholar 

  121. Pinna, L. A. (1990) Casein kinase 2: an “eminence grise” in cellular regulation? Biochim. Biophys. Acta 1054, 267–284.

    Article  PubMed  CAS  Google Scholar 

  122. Meisner, H. and Czech, M. P. (1991) Phosphorylation of transcriptional factors and cell-cycle-dependent proteins by casein kinase II. Curr. Opin. Cell Biol. 3, 474–483.

    Article  PubMed  CAS  Google Scholar 

  123. Allende, J. E. and Allende, C. C. (1995) Protein kinases. 4. Protein kinase CK2: an enzyme with multiple substrates and a puzzling regulation. FASEB J. 9, 313–323.

    PubMed  CAS  Google Scholar 

  124. Wu, X., Hepner, K., Castelino-Prabhu, S., et al. (2000) Evidence for regulation of the PTEN tumor suppressor by a membrane-localized multi-PDZ domain containing scaffold protein MAGI-2. Proc. Natl. Acad. Sci. USA 97, 4233–4238.

    Article  PubMed  CAS  Google Scholar 

  125. Wu, Y., Dowbenko, D., Spencer, S., et al. (2000) Interaction of the tumor suppressor PTEN/MMAC with a PDZ domain of MAGI3, a novel membrane-associated guanylate kinase. J. Biol. Chem. 275, 21477–21485.

    Article  PubMed  CAS  Google Scholar 

  126. Tamura, M., Gu, J., Matsumoto, K., Aota, S., Parsons, R., and Yamada, K. M. (1998) Inhibition of cell migration, spreading, and focal adhesions by tumor suppressor PTEN. Science 280, 1614–1617.

    Article  PubMed  CAS  Google Scholar 

  127. Gu, J., Tamura, M., Pankov, R., et al. (1999) Shc and FAK differentially regulate cell motility and directionality modulated by PTEN. J. Cell Biol. 146, 389–403.

    Article  PubMed  CAS  Google Scholar 

  128. Maier, D., Jones, G., Li, X., et al. (1999) The PTEN lipid phosphatase domain is not required to inhibit invasion of glioma cells. Cancer Res. 59, 5479–5482.

    PubMed  CAS  Google Scholar 

  129. Rodrigues, G. A., Falasca, M., Zhang, Z., Ong, S. H., and Schlessinger, J. (2000) A novel positive feedback loop mediated by the docking protein Gab1 and phosphatidylinositol 3-kinase in epidermal growth factor receptor signaling. Mol. Cell. Biol. 20, 1448–1459.

    Article  PubMed  CAS  Google Scholar 

  130. Gimm, O., Attie-Bitach, T., Lees, J. A., Vekemans, M., and Eng, C. (2000) Expression of the PTEN tumour suppressor protein during human development. Hum. Mol. Genet. 9, 1633–1639.

    Article  PubMed  CAS  Google Scholar 

  131. Torres, J. and Pulido, R. (2001) The tumor suppressor PTEN is phosphorylated by the protein kinase CK2 at its C terminus. Implications for PTEN stability to proteasome-mediated degradation. J. Biol. Chem. 276, 993–998.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pathology, Columbia University, New York, NY

    Ramon Parsons

  2. Institute of Cancer Genetics, College of Physicians and Surgeons, Columbia University, New York, NY

    Laura Simpson

Authors
  1. Ramon Parsons
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Laura Simpson
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Departments of Medicine, Genetics, and Pharmacology, University of Pennsylvania School of Medicine, Philadelphia, PA

    Wafik S. El-Deiry MD, PhD

Rights and permissions

Reprints and permissions

Copyright information

© 2003 Humana Press Inc.

About this protocol

Cite this protocol

Parsons, R., Simpson, L. (2003). PTEN and Cancer. In: El-Deiry, W.S. (eds) Tumor Suppressor Genes. Methods in Molecular Biology™, vol 222. Humana Press, Totowa, NJ. https://doi.org/10.1385/1-59259-328-3:147

Download citation

  • DOI: https://doi.org/10.1385/1-59259-328-3:147

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-0-89603-986-5

  • Online ISBN: 978-1-59259-328-6

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics

Search

Navigation